Strengthening Pharmaceutical Import Compliance Systems in The United States: A Trade Compliance Approach to Combating Falsified Medicines
Clinical Medicine And Health Research Journal · 06.04.2026 · 6 (02) · 1677-1686
DOI: 10.18535/cmhrj.v6i02.583 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine And Health Research Journal, online erschienen am 06.04.2026. Verfasst von Oluchi Beatrice Aneke. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The United States has become increasingly dependent on imported pharmaceutical products and active pharmaceutical ingredients (APIs), reflecting the globalization of drug manufacturing and supply chains. While this shift has improved cost efficiency and production scalability, it has simultaneously introduced significant vulnerabilities, particularly the growing risk of falsified and substandard medicines entering regulated markets. These risks pose serious threats to patient safety, treatment efficacy, and broader public health outcomes. Despite the existence of regulatory frameworks such as the Drug Supply Chain Security Act (DSCSA), there remains a critical gap in the integration of trade compliance mechanisms with public health protection systems. This study adopts an analytical and policy-oriented approach to evaluate the effectiveness of pharmaceutical import compliance systems in the United States, with particular emphasis on trade compliance components including product classification, documentation integrity, audit procedures, and cross-border regulatory coordination. The findings suggest that robust compliance frameworks significantly enhance supply chain traceability, reduce exposure to counterfeit and substandard drugs, and strengthen regulatory enforcement capabilities. The study contributes by proposing a compliance-driven model that systematically links trade compliance practices with public health safeguards, offering a practical pathway for mitigating risks associated with global pharmaceutical supply chains. Strengthening these systems is essential for ensuring drug safety, improving regulatory oversight, and protecting public health in an increasingly interconnected global market.
Zitieren
APA
Aneke, O. B. (2026). Strengthening Pharmaceutical Import Compliance Systems in The United States: A Trade Compliance Approach to Combating Falsified Medicines. Clinical Medicine And Health Research Journal, 6(02), 1677-1686. https://doi.org/10.18535/cmhrj.v6i02.583
Vancouver
Aneke OB. Strengthening Pharmaceutical Import Compliance Systems in The United States: A Trade Compliance Approach to Combating Falsified Medicines. Clinical Medicine And Health Research Journal. 2026;6(02):1677-1686. doi:10.18535/cmhrj.v6i02.583
BibTeX
@article{Aneke2026,
author = {Aneke, Oluchi Beatrice},
title = {Strengthening Pharmaceutical Import Compliance Systems in The United States: A Trade Compliance Approach to Combating Falsified Medicines},
journal = {Clinical Medicine And Health Research Journal},
year = {2026},
volume = {6},
number = {02},
pages = {1677--1686},
doi = {10.18535/cmhrj.v6i02.583}
}
EUVIMED